Literature DB >> 8011808

Allergic bronchopulmonary mycosis caused by the basidiomycetous fungus Schizophyllum commune.

K Kamei1, H Unno, K Nagao, T Kuriyama, K Nishimura, M Miyaji.   

Abstract

We describe, to our knowledge, the first case of allergic bronchopulmonary mycosis (ABPM) caused by the basidiomycetous fungus Schizophyllum commune in an otherwise healthy woman. Bronchoscopic analysis repeatedly disclosed S. commune hyphae in the bronchi of the lingular lobe; these hyphae were originally misidentified as Aspergillus because the presence of clamp connections was overlooked. A lingular infiltrate with ectatic proximal bronchi, eosinophilia, an elevated serum level of IgE, and antibodies to S. commune supported the diagnosis. It is sometimes difficult to isolate and identify S. commune in clinical specimens, and hence only a limited number of cases of ABPM might have been correctly diagnosed in the past. We suspect, therefore, that some cases of ABPM caused by an allergic reaction to S. commune may be misdiagnosed as allergic bronchopulmonary aspergillosis or eosinophilic pneumonia of unknown origin. The significance of S. commune in allergic bronchopulmonary diseases is discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8011808     DOI: 10.1093/clinids/18.3.305

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  36 in total

1.  In vitro activities of approved and investigational antifungal agents against 44 clinical isolates of basidiomycetous fungi.

Authors:  G M González; D A Sutton; E Thompson; R Tijerina; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  The influence of Schizophyllum commune on asthma severity.

Authors:  Haruhiko Ogawa; Masaki Fujimura; Yasuo Takeuchi; Koichi Makimura
Journal:  Lung       Date:  2011-10-18       Impact factor: 2.584

3.  Allergic bronchopulmonary mycosis due to Alternaria: Case report and review.

Authors:  Bhagteshwar Singh; David W Denning
Journal:  Med Mycol Case Rep       Date:  2012-03-03

4.  Molecular detection of Schizophyllum commune in a case of allergic fungal rhinosinusitis.

Authors:  Prashant Gupta; Nitya Verma; Ajay Kumar Singh; Satya Prakash Agarwal
Journal:  BMJ Case Rep       Date:  2015-05-24

5.  Molecular characterization and in vitro antifungal susceptibility profile of Schizophyllum commune, an emerging basidiomycete in bronchopulmonary mycoses.

Authors:  Anuradha Chowdhary; Shallu Kathuria; Pradeep Kumar Singh; Kshitij Agarwal; Shailendra N Gaur; Pradip Roy; Harbans S Randhawa; Jacques F Meis
Journal:  Antimicrob Agents Chemother       Date:  2013-03-18       Impact factor: 5.191

6.  Nucleotide sequencing for diagnosis of sinusal infection by Schizophyllum commune, an uncommon pathogenic fungus.

Authors:  Olivier Baron; Sophie Cassaing; Josiane Percodani; Antoine Berry; Marie-Denise Linas; Richard Fabre; Elie Serrano; Jean François Magnaval
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

7.  Chronic basidiomycetous endophthalmitis after extracapsular cataract extraction and intraocular lens implantation.

Authors:  K U Bartz-Schmidt; K Tintelnot; M Steffen; M Ozel; B Kirchhof; K Heimann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-09       Impact factor: 3.117

8.  Schizophyllum radiatum, an Emerging Fungus from Human Respiratory Tract.

Authors:  J P Z Siqueira; D Sutton; J Gené; D García; M Guevara-Suarez; C Decock; N Wiederhold; J Guarro
Journal:  J Clin Microbiol       Date:  2016-07-20       Impact factor: 5.948

9.  Diagnostic difficulties caused by a nonclamped Schizophyllum commune isolate in a case of fungus ball of the lung.

Authors:  L Sigler; L M de la Maza; G Tan; K N Egger; R K Sherburne
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

Review 10.  Brain abscess caused by Schizophyllum commune: an emerging basidiomycete pathogen.

Authors:  J D Rihs; A A Padhye; C B Good
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.